GlaxoSmithKline Cork, which was established in 1975, develops and manufactures the active ingredients of medical compounds for both clinical and commercial use. The source of our competitive advantage is the energy and commitment of our employees and we strive to provide the best place for the best people to do their best work. Our mission is to improve the quality of human life to enable people to do more, feel better and to live longer. This mission gives us the purpose to develop innovative medicines and products that help treat and improve the quality of life for millions of people around the world. Many of our employees in our Cork facility are engaged in development chemistry, analytical chemistry, and chemical and process engineering.
The Cork facility is a strategic global new product introduction site within GSK’s manufacturing network. We have a highly automated manufacturing facility, as well as an R&D pilot plant with pilot plant laboratories on site. We are currently the primary production site for a number of GSK’s top selling drugs which treat illnesses such as depression, Type 2 diabetes, congestive heart failure, HIV, ovarian cancer, breast cancer, Parkinson’s disease and arthritis.
GlaxoSmithKline Trading Services Limited (GSKTS), is also located in Cork. See GlaxoSmithKline Trading Services for more information.